Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Mosenergo in 2024 increased electricity generation by 4.9%

1/22/25 MSNG

APRI sales in 2024 increased by 14.38%

1/22/25 APRI

Bank Saint-Petersburg” reported for 2024 by RAS

1/22/25 BSPB

Odnoklassniki launched a deiting service for the audience of 40+

1/22/25 VKCO

NKNH received the first tons of ethylene at the new EP-600 unit

1/21/25 NKNC

Solar Group acquires 49% of Gefest Technologies, a developer of SIEM platforms

1/21/25 RTKM

Pre-IPO Exalter applications will be accepted until February 19

1/21/25 OTCI

Fesco to double agricultural exports in 2024

1/21/25 FESH

Fix Price introduces audio analytics of communication quality at checkouts

1/21/25 FIXP

Exalter has announced a Pre-IPO on MOEX Startup

1/21/25 MOEX